期刊文献+

不同程度亚临床甲状腺功能减退对脂代谢及糖代谢影响和心血管疾病危险性分析 被引量:19

Hyperhomocysteinemia in Type 2 Diabetes Mellitus with Vascular Mild Cognitive Impairment
下载PDF
导出
摘要 目的了解不同程度亚临床甲状腺功能减退症(SCH)对患者血脂、血糖代谢水平、胰岛素敏感性、心血管疾病危险因子的影响,从而了解它们之间的相互关系。方法通过性别、年龄匹配,选择笔者医院2005年6月~2010年6月5年间住院患者共210名,根据TSH水平,将其分为轻症组(82位),重症组(44位),对照组(84位)。分别对3组患者的体重指数(BMI)、甲状腺功能指标(TSH,FT3,FT4)、脂代谢(TC、TG、HDL—C、LDL—C、ApoA、ApoB)、糖代谢及胰岛素抵抗参数(FBS,FINS,HOMA—IR)、心血管疾病危险因子(hsCRP)进行比较,并进行统计学分析;比较SCH组及对照组TC升高、TG升高及患非酒精性脂肪肝患者的比率;对SCH患者的各观察指标变量与TSH进行相关性分析。结果重症SCH组BMI及FT4与轻症SCH组及对照组有显著性差异,TC、LDL—C、ApoB、FINS、CRP在重症及轻症SCH组中显著增高,与对照组比较有统计学差异,TG在重症SCH组比对照组显著性升高;在SCH组ApoB、BMI、LDL—C、FINS、TG与TSH显著正相关,FT4、FT3与TSH显著负相关;TC升高的患者比率及患非酒精性脂肪肝患者比率,SCH组显著高于对照组。结论亚临床甲状腺功能减退症已经造成了正常范围内的FL的显著升高,患者血脂水平,空腹胰岛素水平明显升高,并增加了动脉粥样硬化的危险性和肥胖的可能性,也可能是非酒精性脂肪肝的发病因素之一。SCH虽然症状轻微,但应引起临床医生的充分重视。 Objective To explore the effect of different degree subclinical hypothroidism (SCH) on lipid metabolism, glycometabolism, insulin sensitivity and cardiovascular diseases risk factor. Methods The clinical data of 126 adult patients with subclinical hypothroidism from June 2005 to June 2010 were selected by matching age and sex. It was a retrospective study,and statistical analysis was performed to compare the differences in severe SCH (44 patients), mild SCH ( 82 patients) and control group ( 84 patients) from BMI, TSH, FT3 , FT4 , TC, TG, HDL - C, LDL - C, ApoA, ApoB, FBS, FINS, HOMA - IR and hsCRP. Correlation analysis was estimated between TSH and above parameter in patients with SCH. Results BMI and FT4 were significantly different in patients with severe SCH as compared with mild SCH and control group. TC, LDL - C, ApoB, FINS, CRP was significantly higher in the mild and severe SCH group as compared to the control group. There was significant difference in TG between servere SCH and control group. TSH was found to have positive correlation with ApoB, BMI, LDL - C, FINS, TG in SCH. Patients with SCH exhibited elevated incidence rate of nonacohol fatty liver and hypercholesterolemia. Conclusion Subclinical hypothroidism would lead to heighten FT4 in normal limits. Patients exhibited elevated serum Lipid and FINS. SCH easily progress nonacohol fatty liver and atherosclerosis. It is important to pay close attention to SCH for clinician.
出处 《医学研究杂志》 2011年第6期127-130,共4页 Journal of Medical Research
关键词 亚临床甲状腺功能减退症 代谢综合征 脂代谢 胰岛素抵抗 超敏C反应蛋白 非酒精性脂肪肝 Subclinical hypothroidism Metabolism syndrome Lipid metabolism Insulin resistance High sensitive C reactive protein Nonacohol fatty liver
  • 相关文献

参考文献14

  • 1SurksM I,Ortiz E, Daniels GH,et al. Subclinical thyroid disease: scientific review and guide lines for diagnosisand management. JAMA, 2004,291 (2) :228 -238.
  • 2非酒精性脂肪性肝病诊疗指南(2010年修订版)[J].中华肝脏病杂志,2010,18(3):163-166. 被引量:1152
  • 3史轶繁.协和内分泌和代谢学.2版.科学出版社,2000:1012.
  • 4Sasaki S, Kawai K, Honjo Y, et al. Thyroid hormones and lipid metabolism [ J ].Nippon Rinsho, 2006,64 ( 12 ) : 2323 - 2329.
  • 5WalshJP, Bremner AP, Bulsara MK, et al. Thyroid dysfunction and serum lipids: a community based study[ J]. Clin Endocrinol, 2005, 63 (6) :670 -675.
  • 6谢玲玎,高燕明,卢桂芝,蒋秋明,郭晓蕙,高妍.亚临床甲状腺功能减退症与高脂血症及非酒精性脂肪肝的相关性研究[J].中华内分泌代谢杂志,2006,22(6):554-557. 被引量:22
  • 7Liangpunsakul S,Chalasanl N, Is hypothyroidism a risk factor for nonalcoholic steatohepatitis [ J ]. Clin Gastroenterol, 2003,37:340 - 343.
  • 8Perra A, Simbua G, Simbula M,et al. Thyroid hormone ( T3 ) and TRbeta angonist GC - 1 inhibit/reverse nonalcoholic fatty liver in rats[J]. FASEB,2008,22(8) ;2981 - 2989.
  • 9Zhu X, Cheng SY,et al. New insights into regulation of lipid metabo- lism by thyroid hormone [ J ]. Curr Opin Endocrinol Diabetes Obes, 2010,17(5) :408-413.
  • 10Duntas L H,Wartof sky L. Cardiovascular Risk and subclinical hypot- hyroidism:focus on lipids and new emerging risk factors, what is the evidence "? [ J]. Thyroid,2007,17 ( 11 ) : 1075 - 1084.

二级参考文献24

  • 1Fan, Jian-Gao,Peng, Yong-De.Metabolic syndrome and non-alcoholic fatty liver disease:Asian definitions and Asian studies[J].Hepatobiliary & Pancreatic Diseases International,2007,6(6):572-578. 被引量:42
  • 2范建高.糖尿病与肝病的关系及其诊治对策[J].中华糖尿病杂志,2009,1(4). 被引量:30
  • 3Liangpunsakul S, Chalasanl N. Is hypothyroidism a risk factor for nonalcoholic steatohepatitis? J Clin Gastroenterol, 2003,37:340-343.
  • 4Canaris GJ, Manowitz NR, Mayor G, et al. The Colorado thyroid disease prevalence study. Arch Intern Med, 2000,160:5260-5534.
  • 5Bindels A J, Westendorp RG, Frolich M. The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: a need for case-finding? Clin Endocrinol (Oxf) ,1999,50:217-220.
  • 6Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol(Oxf), 1977,7:481-493.
  • 7Lindeman RD, Schade DS, LaRue A, et al. Subclinical hypothyroidism in a biethnic, urban community. J Am Geriatr Soc, 1999,47:703-709.
  • 8Hollowell JG, Staehling NW, Flanders WD. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994 ):National Health and Nutrition Examination Survey (NHANES Ⅲ). J Clin Endocrinol Metab, 2002, 87 : 489-499, Comment in : J Clin Endocrinol Metab, 2002,87:486-488.
  • 9Pirich C, Mullner M, Sinzinger H. Prevalence and relevance of thyroid dysfunction in 1922 cholesterol screening participants. J Clin Epidemiol, 2000,53:623-629.
  • 10Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol, 2003,98:960-967.

共引文献1228

同被引文献189

引证文献19

二级引证文献123

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部